ID: ALA2208336

Max Phase: Preclinical

Molecular Formula: C24H32N6O5

Molecular Weight: 484.56

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)cc1OC

Standard InChI:  InChI=1S/C24H32N6O5/c1-34-19-11-10-16(14-20(19)35-2)22(32)29-17(9-6-12-28-24(26)27)23(33)30-18(21(25)31)13-15-7-4-3-5-8-15/h3-5,7-8,10-11,14,17-18H,6,9,12-13H2,1-2H3,(H2,25,31)(H,29,32)(H,30,33)(H4,26,27,28)/t17-,18-/m0/s1

Standard InChI Key:  VROVWYHTEPXFBG-ROUUACIJSA-N

Associated Targets(Human)

Neuropeptide FF receptor 2 533 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Neuropeptide FF receptor 1 514 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 484.56Molecular Weight (Monoisotopic): 484.2434AlogP: 0.28#Rotatable Bonds: 13
Polar Surface Area: 181.65Molecular Species: BASEHBA: 6HBD: 6
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 8#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.08CX Basic pKa: 11.70CX LogP: -0.17CX LogD: -2.23
Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.13Np Likeness Score: -0.17

References

1. Gealageas R, Schneider S, Humbert JP, Bertin I, Schmitt M, Laboureyras E, Dugave C, Mollereau C, Simonnet G, Bourguignon JJ, Simonin F, Bihel F..  (2012)  Development of sub-nanomolar dipeptidic ligands of neuropeptide FF receptors.,  22  (24): [PMID:23131340] [10.1016/j.bmcl.2012.10.049]

Source